Restoring Safeguards for Dangerous Abortion Drugs Act

# Summary of HR 5646: Restoring Safeguards for Dangerous Abortion Drugs Act **What the Bill Would Do:** This bill would restrict the use of mifepristone, a medication used in medication abortion procedures. Specifically, it would reinstate stricter federal regulations on how the drug can be distributed and used, rolling back recent FDA policy changes that expanded access to the medication. The bill would affect the conditions under which the drug can be prescribed, who can prescribe it, and how it must be administered to patients. **Who It Affects:** The bill would directly impact women seeking medication abortion services, healthcare providers (particularly those in non-hospital settings like clinics and offices), and potentially the pharmaceutical companies that distribute the drug. It would also affect abortion access nationwide by limiting availability of this method. **Current Status:** As of now, HR 5646 remains in committee and has not advanced to a floor vote.

The bill was introduced in the 119th Congress by Rep. Mary E. Miller (R-IL). *Note: This summary is based on the bill's title and sponsorship information. For complete details on specific provisions, consult the full legislative text.*.